Elevated Levels of Interleukin-33 in the Nasal Secretions of Patients with Allergic Rhinitis
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background: Interleukin (IL)-33, which is a member of the IL-1 family of cytokines, is now recognized as an important contributor to Th2-type immune responses. We examined whether the levels of IL-33 in sera and nasal secretions are upregulated in allergic rhinitis (AR) patients, and we tested for correlations between the IL-33 level and the parameters of atopy and the nasal symptom score. Methods: The study included 24 Japanese cedar pollinosis patients (12 male and 12 female patients with a mean age of 47.7 years) with a history of moderate-to-severe AR, 14 house-dust-mite-sensitized patients with AR (9 male and 5 female patients with a mean age of 42 years) and 8 normal controls. We used Japan Rhinoconjunctivitis Quality-of-Life Questionnaire sheets to evaluate the nasal symptoms. We collected sera and nasal secretions to examine the level of IL-33 protein by ELISA. Results: IL-33 protein was not detected in the serum of any of the subjects. However, the IL-33 level in nasal secretions was significantly elevated in patients with Japanese cedar pollinosis at peak season and in patients with perennial AR compared to Japanese cedar pollinosis patients at preseason and the normal controls. Furthermore, IL-33 in nasal secretions correlated significantly with the total nasal symptom score. Conclusions: Our results suggest that IL-33 in nasal secretions may be related to exacerbation of AR, including that of Japanese cedar pollinosis cases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, levels of IL-33 in nasal secretions have been shown to correlate with total nasal symptom scores.400”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [400]
Citations
Cites
Asher, M. I., Montefort, S., Björkstén, B., Lai, C. K., Strachan, D. P., Weiland, S. K., & Williams, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69283-0 · Cited by 4,223
A large-scale, consortium-based genomewide association study of asthma
Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von Mutius, E., Farrall, M., Lathrop, M., & Cookson, W. O. C. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906312 · Cited by 1,818
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., & Lee, R. T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30634 · Cited by 1,044
Disease-associated functions of IL-33: the new kid in the IL-1 family
Liew, F. Y., Pitman, N. I., & McInnes, I. B. (2010) · Nature Reviews Immunology · doi:10.1038/nri2692 · Cited by 1,003
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Lüthi, A. U., Cullen, S. P., McNeela, E. A., Duriez, P. J., Afonina, I. S., Sheridan, C., Brumatti, G., Taylor, R. C., Kersse, K., Vandenabeele, P., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.007 · Cited by 677
Thymic stromal lymphopoietin: master switch for allergic inflammation
Liu, Y.-J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051745 · Cited by 576
A novel IL-1 family cytokine, IL-33, potently activates human eosinophils
Cherry, W. B., Yoon, J., Bartemes, K. R., Iijima, K., & Kita, H. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.005 · Cited by 499
Increased IL-33 expression by epithelial cells in bronchial asthma
Préfontaine, D., Nadigel, J., Chouiali, F., Audusseau, S., Semlali, A., Chakir, J., Martin, J. G., & Hamid, Q. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.935 · Cited by 454
Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells
Allakhverdi, Z., Smith, D. E., Comeau, M. R., & Delespesse, G. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2051 · Cited by 431
Research works printed but not linked: 3
- 10.2332%2fallergolint.o-08-550 · DOI
- 10.1016%2fj.immuni.2005.09.015 · DOI · Paper page
- 10.1073%2fpnas.1003059107 · DOI · Paper page
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Golebski, K., Layhadi, J. A., Sahiner, U., Steveling-Klein, E. H., Lenormand, M. M., Li, R. C. Y., Bal, S. M., Heesters, B. A., Vilà-Nadal, G., Hunewald, O., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.013 · Cited by 250
The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention
Jayalatha, A. K. S., Hesse, L., Ketelaar, M. E., Koppelman, G. H., & Nawijn, M. C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107847 · Cited by 171
Role of innate lymphoid cells in allergic diseases
Pasha, M. A., Patel, G., Hopp, R., & Yang, Q. (2019) · Allergy and Asthma Proceedings · doi:10.2500/aap.2019.40.4217 · Cited by 98
“IL-25, IL-33, and TSLP were detected in the nasal lavage from patients with house-dust mite (HDM) sensitivity.(23,24) Furthermore, IL-33 and TSLP messenger RNA (mRNA) levels were high in nasal epithelium of patients with AR.”
BackgroundCytokine Profiles in Allergic Rhinitis
Scadding, G. W. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0435-7 · Cited by 97
Role of interleukin 33 in respiratory allergy and asthma
Makrinioti, H., Toussaint, M., Jackson, D. J., Walton, R. P., & Johnston, S. L. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70261-3 · Cited by 83
Leaker, B. R., Malkov, V., Mogg, R., Ruddy, M., Nicholson, G. C., Tan, A. J., Tribouley, C., Chen, G., Lepeleire, I. D., Calder, N. A., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.74 · Cited by 85
Interleukin-33: Its Emerging Role in Allergic Diseases
Ding, W., Zou, G.-L., Zhang, W. K., Lai, X., Chen, H.-W., & Xiong, L. (2018) · Molecules · doi:10.3390/molecules23071665 · Cited by 85
“Interestingly, study including 24 Japanese cedar (JC) pollinosis patients and 14 HDM-sensitized patients with AR has found that IL-33 protein is not detected in the serum, but IL-33 level is increased in sinus mucosa and significantly correlated with the total nasal symptom score [54].”
BackgroundSaito, K., Orimo, K., Kubo, T., Tamari, M., Yamada, A., Motomura, K., Sugiyama, H., Matsuoka, R., Nagano, N., Hayashi, Y., et al. (2023) · Allergy · doi:10.1111/all.15762 · Cited by 83
Role of Interleukin-33 in Innate-Type Immune Cells in Allergy
Nakae, S., Morita, H., Ohno, T., Arae, K., Matsumoto, K., & Saito, H. (2013) · Allergology International · doi:10.2332/allergolint.13-rai-0538 · Cited by 74
The paradigm of cytokine networks in allergic airway inflammation
Pawankar, R., Hayashi, M., Yamanishi, S., & Igarashi, T. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000129 · Cited by 80
“Elevated levels of IL-33 were detected in nasal secretions, but not in serum, in patients with Japanese cedar pollinosis at peak season, and in patients with perennial allergic rhinitis as compared with preseason and the normal controls [61].”
BackgroundExpression of IL‐33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps
Baba, S., Kondo, K., Kanaya, K., Suzukawa, K., Ushio, M., Urata, S., Asakage, T., Kakigi, A., Suzukawa, M., Ohta, K., et al. (2013) · The Laryngoscope · doi:10.1002/lary.24462 · Cited by 74
Thymic stromal lymphopoietin: a central regulator of allergic asthma
Watson, B. M., & Gauvreau, G. M. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.915314 · Cited by 67
“Elevated IL-33 serum levels have been found in patients during anaphylactic shock, as well as severe asthma and allergic rhinitis patients [107-112].”
BackgroundAllergen-Dependent Differences in ILC2s Frequencies in Patients With Allergic Rhinitis
Fan, D., Wang, X., Wang, M., Wang, Y., Zhang, L., Li, Y., Fan, E., Cao, F., Crombruggen, K. V., & Zhang, L. (2016) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2016.8.3.216 · Cited by 63
“Mean age (range), (yr) 30 (25-50) 29 (19-46) 31.”
IL-33 and Thymic Stromal Lymphopoietin in mast cell functions
Saluja, R., Zoltowska, A., Ketelaar, M. E., & Nilsson, G. P. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.047 · Cited by 59
“Moreover, in vivo clinical studies point towards deregulated levels of these molecules on a protein level in patients with allergic disease (Asaka et al., 2012; Gluck et al., 2012; Papazian et al., 2014; Prefontaine et al., 2010; Savinko et al., 2012; Tamagawa-Mineoka et al., 2014).”
BackgroundSerum IL-33 Is Elevated in Children with Asthma and Is Associated with Disease Severity
Mahneh, S. B., Movahedi, M., Aryan, Z., Bahar, M. A., Rezaei, A., Sadr, M., & Rezaei, N. (2015) · International Archives of Allergy and Immunology · doi:10.1159/000442413 · Cited by 46
The challenge of measuring IL ‐33 in serum using commercial ELISA : lessons from asthma
Ketelaar, M. E., Nawijn, M. C., Shaw, D. E., Koppelman, G. H., & Sayers, I. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12718 · Cited by 46
Mitthamsiri, W., Pradubpongsa, P., Sangasapaviliya, A., & Boonpiyathad, T. (2018) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2018.10.6.662 · Cited by 44
Baumann, R., Rabaszowski, M., Stenin, I., Tilgner, L., Gärtner-Akerboom, M., Scheckenbach, K., Wiltfang, J., Chaker, A. M., Schipper, J., & Wagenmann, M. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12148 · Cited by 43
Jang, T. Y., & Kim, Y. H. (2015) · International Neurourology Journal · doi:10.5213/inj.2015.19.3.142 · Cited by 38
“Therefore, it is highly probable that IL-33 is a marker of disease severity in allergic rhinitis [32,33].”
BackgroundThe Role of Interleukin-33 in Rhinitis
Rogala, B., & Glück, J. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0338-z · Cited by 35
“The higher levels of IL-33 in nasal secretions from house dust mite-sensitive patients with perennial allergic rhinitis was observed [52].”
BackgroundCavagnero, K. J., & Doherty, T. A. (2017) · Journal of Cytokine Biology · doi:10.4172/2576-3881.1000116 · Cited by 33
“In support of ILC2 activation in AR, IL-33 expression was found to be increased in the nasal secretions of patients with AR compared to control patients [85].”
Regulation of Airway Epithelial-Derived Alarmins in Asthma: Perspectives for Therapeutic Targets
Hansi, R. K., Ranjbar, M., Whetstone, C. E., & Gauvreau, G. M. (2024) · Biomedicines · doi:10.3390/biomedicines12102312 · Cited by 34
“Increased alarmin expression is also observed in the upper airways of asthmatics with comorbid allergic rhinitis (AR), correlating with disease severity [26–28].”
BackgroundHan, H., Chen, G., Zhang, B., Zhang, X., He, J., Du, W., & Li, M. D. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1291100 · Cited by 27
“The elevated level of IL-33 in serum correlated significantly with the severe symptoms of AR patients (34), and immunotherapy can decrease IL-33 levels and improve AR symptoms (35).”
BackgroundKabata, H., Motomura, Y., Kiniwa, T., Kobayashi, T., & Moro, K. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-8387-9_6 · Cited by 29
Song, W., Wang, C., Zhou, J., Pan, S., & Lin, S. (2017) · ORL · doi:10.1159/000484527 · Cited by 27
Active smoking effect in allergic rhinitis
Gómez, R. M., Croce, V. H., Zernotti, M. E., & Muino, J. C. (2021) · World Allergy Organization Journal · doi:10.1016/j.waojou.2020.100504 · Cited by 22
“Conflicting data on the correlation between serum and nasal levels have previously been reported, including being undetectable in serum but present in nasal specimens.(44,50) Nevertheless, IL 33 in nasal secretions expresses an inflammation directed”
BackgroundHu, G., Xi-ling, Z., Zhu, W., Wu, L., Dan, H., Wu, X., Wen-yun, Z., & Weixu, H. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.12.002 · Cited by 20
Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases
Matsushita, K., Kato, Y., Akasaki, S., & Yoshimoto, T. (2015) · Allergology International · doi:10.1016/j.alit.2014.12.008 · Cited by 19
IL‐1β promotes immunoregulatory responses in human blood basophils
Iype, J. M., Odermatt, A., Bachmann, S., Coeudevez, M., & Fux, M. (2021) · Allergy · doi:10.1111/all.14760 · Cited by 20
Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis
Yuanming, W., Li, C., Xu, Y., Xu, D., Yang, G., Liao, F., & Luo, X. (2018) · The Indian Journal of Pediatrics · doi:10.1007/s12098-018-2703-3 · Cited by 17
Comparative analysis of cytokine release from epithelial cell cultures of the upper airway
Shiozawa, A., Miwa, M., Ono, N., Homma, H., Hirotsu, M., & Ikeda, K. (2015) · Rhinology Journal · doi:10.4193/rhin14.078 · Cited by 17
Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification?
Erfurt, S., Hoffmeister, M., Oess, S., Asmus, K., Ritter, O., Patschan, S. A., & Patschan, D. (2021) · Journal of Circulating Biomarkers · doi:10.33393/jcb.2021.2327 · Cited by 15
“Comparable findings were reported by Asaka et al (17), who also employed the Quantikine kit.”
Soluble IL-33 receptor predicts survival in acute kidney injury
Erfurt, S., Hoffmeister, M., Oess, S., Asmus, K., Patschan, S. A., Ritter, O., & Patschan, D. (2022) · Journal of Circulating Biomarkers · doi:10.33393/jcb.2022.2386 · Cited by 17
“(20), who also employed the Quantikine kit.”
Diagnosis and Treatment in Asthma and Allergic Rhinitis: Past, Present, and Future
Espada-Sánchez, M., María, R. S. D. S., Martín‐Astorga, M. D. C., Lebrón‐Martín, C., Delgado, M. J., Eguíluz‐Gracia, I., Rondón, C., Mayorga, C., Torres, M. J., Aranda, C. J., et al. (2023) · Applied Sciences · doi:10.3390/app13031273 · Cited by 14
Sarah, C. O. S., & Ashari, N. S. M. (2024) · Cureus · doi:10.7759/cureus.71409 · Cited by 15
“In addition, the IL-33 level was increased in the sinus mucosa and significantly correlated with the total nasal symptom score in HDM-sensitized AR patients [91].”
Voloshyna, I., Mucci, T., Sher, J., Fonacier, L. S., Littlefield, M. J., Carsons, S., & Reiss, A. B. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12516 · Cited by 12
“Additionally, Asaka et al. [38] found elevated levels of IL-33 in the nasal secretions of patients experiencing allergic rhinitis exacerbations compared to healthy controls.”
BackgroundGroup 2 Innate Lymphoid Cells in Allergic Rhinitis
Wang, S., Liu, X., Lin, X., Lv, X., & Zhang, H. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s485128 · Cited by 12
Jamali, M. C., Mohamed, A. H., Jamal, A., Kamal, M. A., Abdulmonem, W. A., Saeed, B. A., Mansuri, N., Ahmad, F., Mudhafar, M., Shafie, A., et al. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00438-w · Cited by 12
“…i n c r e a s e d i n s i n u s m u c o s a - s i g n i fi c a n t c o rr e l a t i o n w i t h t h e t o t a l n a s a l s y m p t o m s c o r e [ 171 ] stages of allergic airway inflammation, may help explain the involvement of the IL-33/ST2 pathway in the genetic susceptibility to human…”
Nasr, W. F., Sorour, S., El-Bahrawy, A. T., Boghdadi, G., & Shahaway, A. A. E. (2017) · International Archives of Otorhinolaryngology · doi:10.1055/s-0037-1605596 · Cited by 9
Matsumoto, K., Kouzaki, H., Kikuoka, H., Kato, T., Tojima, I., Shimizu, S., & Shimizu, T. (2018) · Allergology International · doi:10.1016/j.alit.2018.05.009 · Cited by 9
Ran, H., Xiao, H., Zhou, X., Guo, L., & Lu, S. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9232 · Cited by 9
“Although IL‐33 is not always detectable in serum, increased levels of IL‐33 in sinus mucosa have also been reported in patients with JC pollinosis and house dust mite (HDM)‐sensitized AR (53).”
BackgroundAdachi, T., Yasuda, K., Muto, T., Serada, S., Yoshimoto, T., Ishii, K. J., Kuroda, E., Araki, K., Ohmuraya, M., Naka, T., et al. (2020) · International Immunology · doi:10.1093/intimm/dxaa031 · Cited by 9
The Impact of Cytokines on Health-Related Quality of Life in Adolescents with Allergic Rhinitis
Krsmanović, L., Arsovic, N. A., Bokonjić, D., Nesic, V. S., Dudvarski, Z., Pavlović, D., Tanasković, M. D., Ristić, S., Elez-Burnjaković, N., Balaban, R., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12020428 · Cited by 7
“IL-33, which is an alarmin, is localized in the nucleus of human endothelial and epithelial cells [81], and it is released in response to allergens but also to non-allergic stimuli, so it can be increased in nasal secretions in patients with AR and NAR [82].”
BackgroundArani, M. H., Nikafarin, S., & Gilasi, H. (2021) · Iranian Journal of Pediatrics · doi:10.5812/ijp.105094 · Cited by 6
Interleukin-33: A Multifunctional Alarmin that Promotes Both Health and Disease
Matsushita, K., & Yoshimoto, T. (2013) · Springer eBooks · doi:10.1007/978-4-431-54442-5_11 · Cited by 5
Tang, G., Lan, Y., Do, B., Lu, J., Yang, K., Chai, L., Chen, F., & Tian, L. (2022) · Medicine · doi:10.1097/md.0000000000032019 · Cited by 4
“[27–29] Some studies have found that after the nasal epithelium of AR patients is stimulated by allergens, the pro-inflammatory cytokines in the epithelium increase, and IL-25, IL-33 and TSLP can be detected in the nasal lavage fluid of patients with house dust mite allergy.[30,31] However, the level of IL-25 released…”
BackgroundInnate and adaptive immunity in allergic airway disease
Scadding, G. K., & Scadding, G. W. (2021) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000800 · Cited by 4
Hamzah, I. H., Saeed, N. A.-H. A. A. H., & Ali, A. N. M. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00296 · Cited by 3
An interleukin-33 gene polymorphism is a modifier for eosinophilia in rats
Luo, H., Higuchi, K., Matsumoto, K., & Mori, M. (2013) · Genes and Immunity · doi:10.1038/gene.2013.7 · Cited by 2
“Also, the IL-33 level in nasal secretions was significantly elevated in patients with allergic rhinitis.(32) Furthermore in mouse ovalbumin or helminthic parasites-induced airway”
BackgroundYuanming, W., Li, C., Luo, X., Xu, D., Xu, Y., Li, G., Liao, F., & Tan, S. (2017) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-017-4807-1 · Cited by 2
RetractedIL-33 is associated with allergy in children sensitized to the cat
Smejda, K., Borkowska, A., Jerzyńska, J., Brzozowska, A., Stelmach, W., & Stelmach, I. (2019) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2019.06.006 · Cited by 1
SOLIMAN, M., Hossenbaccus, L., Rawls, M., Thiele, J., & Ellis, A. K. (2026) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2026.03.004 · Cited by 1
Abelius, M. S. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-106220
“Accordingly, increased IL-25, IL-33 and TSLP expression has been reported in lesional AD skin, nasal mucosa and elevated levels in nasal secretions in subjects with allergic rhinitis [77, 79, 80].”
Comparison of serum interleukin-33 levels in children with allergic respiratory diseases
Milanović, B., Vijatov-Djuric, G., Stojsic, M., Milutinović, A., & Stojčević-Maletić, J. (2020) · Medicinski pregled · doi:10.2298/mpns2004088m
“showed that examinees with severe AR have higher IL-33 levels of nasal secretion [26].”
Background神前, 英. (2019) · Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · doi:10.7248/jjrhi.58.82
健治, 松. (2015) · Nihon Shoni Arerugi Gakkaishi The Japanese Journal of Pediatric Allergy and Clinical Immunology · doi:10.3388/jspaci.29.227
The role of interleukin-33 in the pathogenesis, and treatment of severe asthma
Syabbalo, N. (2021) · Journal of Lung Pulmonary & Respiratory Research · doi:10.15406/jlprr.2021.08.00266
Study of Interleukin 33 Gene Polymorphism in Egyptian Patients with Allergic Rhinitis
(2024) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2024.348395
“…24 patients with Japanese cedar (JC) pollinosis and 14 patients with HDM sensitization and AR revealed that while IL-33 protein is not detectable in the serum, its concentration is elevated in the sinus mucosa and exhibits a significant correlation with the overall nasal symptom score [28] .”
BackgroundLaboratory animal allergy: a changing world
Canizales, J. (2020) · Spiral (Imperial College London) · doi:10.25560/90008
Metadata
- Authors
- Asaka, D., Yoshikawa, M., Nakayama, T., Yoshimura, T., Moriyama, H., & Otori, N.
- Affiliations
- Jikei University School of Medicine (JP)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2012
- Volume
- 158
- Issue
- Suppl. 1
- Pages
- 47-50
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W1975002923
- Cited by
- 59
- References
- 17
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 7 · 2014: 6 · 2013: 6
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- IL-33, allergic rhinitis, nasal secretions, Japanese cedar pollinosis, house dust mite sensitization, Th2 immune response, IL-1 family cytokines, atopy, nasal symptom score, perennial allergic rhinitis, seasonal exacerbation
- MeSH terms
- Interleukin-33, Adult, Allergens, Animals, Female, Rhinitis, Allergic, Seasonal, Humans, Immunoglobulin E, Interleukins, Male, Middle Aged, Nasal Mucosa, Pollen, Rhinitis, Allergic, Perennial, Cryptomeria, Pyroglyphidae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.